Hemorrhagic transformation: A review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke

Frontiers in Neurology

Volumn 4 JUN, Issue , 2013, Pages

  Sussman, Eric S ^a   Connolly Jr , E Sander ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Acute ischemic stroke; Fibrinolysis; Hemorrhagic transformation; Intracerebral hemorrhage; Mechanical thrombectomy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ALTEPLASE; FIBRINOLYTIC AGENT; PROUROKINASE;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; MECHANICAL THROMBECTOMY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RECANALIZATION;

EID: 84883525928     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00069     Document Type: Article

References (50)

1. Ariesen, M. J., Claus, S. P., Rinkel, G. J. E., and Algra, A. (2003). Risk factors for intracerebral hemorrhage in the general population. Stroke 34, 2060-2065. doi:10.1161/01.STR.0000080678.09344.8D
2. Broderick, J., Connolly, S., Feldmann, E., Hanley, D., Kase, C., Krieger, D., et al. (2007). Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group. Stroke 38, 2001-2023. doi:10.1161/STROKEAHA.107.183689
3. Broderick, J. P., Palesch, Y. Y., Demchuk, A. M., Yeatts, S. D., Khatri, P., Hill, M. D., et al. (2013). Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368, 893-903. doi:10.1056/NEJMoa1214300
4. Castaño, C., Dorado, L., Guerrero, C., Millán, M., Gomis, M., Perez de la Ossa, N., et al. (2010). Mechanical thrombectomy with the solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 41, 1836-1840. doi:10.1161/STROKEAHA.110.584904
5. Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., and Hamilton, S. (1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 282, 2019-2026. doi:10.1001/jama.282.21.2019
6. Cosgrove, G. R., Leblanc, R., Meagher-Villemure, K., and Ethier, R. (1985). Cerebral amyloid angiopathy. Neurology 35, 625-631. doi:10.1212/WNL.35.5.625
7. del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., and Gent, M. (1998). PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism. Stroke 29, 4-11. doi:10.1161/01.STR.29.1.4
8. del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., et al. (1992). Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann. Neurol. 32, 78-86. doi:10.1002/ana.410320113
9. Feigin, V. L., Lawes, C. M. M., Bennett, D. A., Barker-Collo, S. L., and Parag, V. (2009). Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 8, 355-369. doi:10.1016/S1474-4422(09)70025-0
10. Fiorelli, M., Bastianello, S., Kummer von, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., et al. (1999). Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 30, 2280-2284. doi:10.1161/01.STR.30.11.2280
11. Flaherty, M. L., Woo, D., Haverbusch, M., Sekar, P., Khoury, J., Sauerbeck, L., et al. (2005). Racial variations in location and risk of intracerebral hemorrhage. Stroke 36, 934-937. doi:10.1161/01.STR.0000160756.72109.95
12. Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., et al. (1999). Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282, 2003-2011. doi:10.1001/jama.282.21.2003
13. Gobin, Y. P., Starkman, S., Duckwiler, G. R., Grobelny, T., Kidwell, C. S., Jahan, R., et al. (2004). MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 35, 2848-2854. doi:10.1161/01.STR.0000147718.12954.60
14. Graham, G. D. (2003). Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 34, 2847-2850. doi:10.1161/01.STR.0000101752.23813.C3
15. Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329. doi:10.1056/NEJMoa0804656
16. Hacke, W., Kaste, M., Fieschi, C., Kummer von, R., Dávalos, A., Meier, D., et al. (1998). Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet 352, 1245-1251. doi:10.1016/S0140-6736(98)08020-9
17. Hajjar, I., and Kotchen, T. A. (2003). Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290, 199-206. doi:10.1001/jama.290.2.199
18. Harrington, H., Heller, H. A., Dawson, D., and Caplan, L. (1983). Intracerebral hemorrhage and oral amphetamine. Arch. Neurol. 40, 503-507. doi:10.1001/archneur.1983.04210070043012t
19. Hornig, C. R., Dorndorf, W., and Agnoli, A. L. (1986). Hemorrhagic cerebral infarction - a prospective study. Stroke 17, 179-185. doi:10.1161/01.STR.17.2.179
20. IMS-II Trial Investigators. (2007). The interventional management of stroke (IMS) II study. Stroke 38, 2127-2135. doi:10.1161/STROKEAHA.107.483131
21. IMS Study Investigators. (2004). Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 35, 904-911. doi:10.1161/01.STR.0000121641.77121.98
22. Janardhan, V., and Qureshi, A. I. (2004). Mechanisms of ischemic brain injury. Curr. Cardiol. Rep. 6, 117-123. doi:10.1007/s11886-004-0009-8
23. Khatri, R., McKinney, A. M., Swenson, B., and Janardhan, V. (2012). Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 79(Suppl. 1), S52-7. doi:10.1212/WNL.0b013e3182697e70
24. Komotar, R. J., Kim, G. H., Otten, M. L., Hassid, B., Mocco, J., Sughrue, M. E., et al. (2008). The role of complement in stroke therapy. Adv. Exp. Med. Biol. 632, 23-33.t
25. Lewandowski, C. A., Frankel, M., Tomsick, T. A., Broderick, J., Frey, J., Clark, W., et al. (1999). Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency Management of Stroke (EMS) Bridging Trial. Stroke 30, 2598-2605. doi:10.1161/01.STR.30.12.2598
26. Lowenstein, D. H., Massa, S. M., and Rowbotham, M. C. (1987). Acute neurologic and psychiatric complications associated with cocaine abuse. Am. J. Med. 83, 841-846. doi:10.1016/0002-9343(87)90640-1
27. Mocco, J., Mack, W. J., Ducruet, A. F., Sosunov, S. A., Sughrue, M. E., Hassid, B. G., et al. (2006). Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ. Res. 99, 209-217. doi:10.1161/01.RES.0000232544.90675.42
28. Multicentre Acute Stroke Trial - Italy (MAST-I) Group. (1995). Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346, 1509-1514.
29. Nogueira, R. G., Lutsep, H. L., Gupta, R., Jovin, T. G., Albers, G. W., Walker, G. A., et al. (2012). Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380, 1231-1240. doi:10.1016/S0140-6736(12)61299-9
30. Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., et al. (2007). Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 38, 2633-2639. doi:10.1161/STROKEAHA.107.488551
31. Okada, Y., Yamaguchi, T., Minematsu, K., Miyashita, T., Sawada, T., Sadoshima, S., et al. (1989). Hemorrhagic transformation in cerebral embolism. Stroke 20, 598-603. doi:10.1161/01.STR.20.5.598
32. Penumbra Pivotal Stroke Trial Investigators. (2009). The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40, 2761-2768. doi:10.1161/STROKEAHA.108.544957
33. Pessin, M. S., del Zoppo, G. J., and Estol, C. J. (1990). Thrombolytic agents in the treatment of stroke. Clin. Neuropharmacol. 13, 271-289. doi:10.1097/00002826-199008000-00001
34. Rossi, D. J., Brady, J. D., and Mohr, C. (2007). Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10, 1377-1386. doi:10.1038/nn2004
35. Sacco, S., Marini, C., Toni, D., Olivieri, L., and Carolei, A. (2009). Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 40, 394-399. doi:10.1161/STROKEAHA.108.523209
36. Saver, J. L., Jahan, R., Levy, E. I., Jovin, T. G., Baxter, B., Nogueira, R. G., et al. (2010). Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380, 1241-1249. doi:10.1016/S0140-6736(12)61384-1
37. Smith, W. S., Sung, G., Saver, J., Budzik, R., Duckwiler, G., Liebeskind, D. S., et al. (2008). Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 39, 1205-1212. doi:10.1161/STROKEAHA.107.49711
38. Smith, W. S., Sung, G., Starkman, S., Saver, J. L., Kidwell, C. S., Gobin, Y. P., et al. (2005). Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36, 1432-1438. doi:10.1161/01.STR.0000171066.25248.1d
39. Sudlow, C. L., and Warlow, C. P. (1997). Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International stroke incidence collaboration. Stroke 28, 491-499. doi:10.1161/01.STR.28.3.491
40. Tarr, R., Hsu, D., Kulcsar, Z., Bonvin, C., Rufenacht, D., Alfke, K., et al. (2010). The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J. Neurointerv. Surg. 2, 341-344. doi:10.1136/jnis.2010.002600
41. The Multicenter Acute Stroke Trial - Europe Study Group. (1996). Thrombolytic therapy with streptokinase in acute ischemic stroke. N. Engl. J. Med. 335, 145-150.
42. The National Institute of Neurological Disorders, Group SR-PSS. (1995). Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587.
43. The National Institute of Neurological Disorders Stroke rtPA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587.
44. The NINDS t-PA Stroke Study Group. (1997). Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28, 2109-2118.
45. Vinters, H. V., and Gilbert, J. J. (1983). Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14, 924-928. doi:10.1161/01.STR.14.6.92
46. Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., et al. (2007). Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369, 275-282. doi:10.1016/S0140-6736(07)60149-4
47. Wahlgren, N. TREVO Investigators. (2012). "Final Results from the TREVO Study," in Proceedings from the International Stroke Conference 2012, New Orleans.
48. Warach, S., and Latour, L. L. (2004). Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35(Suppl. 1), 2659-2661. doi:10.1161/01.STR.0000144051.32131.
49. Zahuranec, D. B., Gonzales, N. R., Brown, D. L., Lisabeth, L. D., Longwell, P. J., Eden, S. V., et al. (2006). Presentation of intracerebral haemorrhage in a community. J. Neurol. Neurosurg. Psychiatr. 77, 340-344. doi:10.1136/jnnp.2005.07716
50. Zodpey, S. P., Tiwari, R. R., and Kulkarni, H. R. (2000). Risk factors for haemorrhagic stroke. Public Health 114, 177-182. doi:10.1038/sj.ph.19006